Показано 0 из 0
Дата |
---|
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
18.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
4.42
|
4.48
|
3.95
|
3.93
|
4.565
|
4.40
|
|
|
10 346 876.57
|
16 218.00
|
3.90
|
3.95
|
4.05
|
3.86
|
4.103
|
3.92
|
|
|
3 767 351.00
|
6 897.00
|
4.04
|
4.09
|
4.06
|
3.93
|
4.21
|
4.09
|
|
|
5 131 672.87
|
10 410.00
|
3.96
|
4.00
|
3.92
|
3.85
|
4.01
|
3.99
|
|
|
2 718 913.76
|
5 582.00
|
3.86
|
3.91
|
3.79
|
3.71
|
3.9199
|
3.90
|
|
|
3 024 543.03
|
6 677.00
|
3.75
|
3.79
|
3.95
|
3.695
|
4.03
|
3.82
|
|
|
5 833 460.52
|
11 196.00
|
3.93
|
3.95
|
3.85
|
3.75
|
4.185
|
3.93
|
|
|
8 546 778.10
|
14 585.00
|
3.74
|
3.77
|
3.90
|
3.30
|
3.90
|
3.70
|
|
|
9 411 843.65
|
16 448.00
|
3.78
|
3.83
|
3.75
|
3.55
|
4.11
|
3.70
|
|
|
18 848 208.36
|
22 292.00
|
3.71
|
3.79
|
3.18
|
3.17
|
3.75
|
3.59
|
|
|
20 391 637.62
|
28 057.00
|
Humacyte Inc (formerly Alpha Healthcare Acquisition Corp) is a developer of a biotechnology and regenerative medicine platform intended to provide potential commercialization for key applications in regenerative medicine and vascular surgery. The company's platform utilizes technology to engineer human, extracellular matrix-based tissues that can be shaped into tubes, sheets, or particulate conformations, with properties similar to native tissues, enabling patients to significantly improve treatment outcomes, including those with vascular disease and those requiring hemodialysis.